Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Gowling WLG (Canada) LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Gowling WLG (Canada) LLP

arrow
The MedTech Conference
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
The MedTech Conference
Not Confirmed

TISAGENLECLEUCEL

Brand Name : KYMRIAH

Patent Number : 2820681

Filing Date : 2011-12-09

Strength per Unit : 1.2x10^6 to 6.0x10^8 CAR - positive viable T cells

Dosage Form : SUSPENSION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2031-12-09

Date Granted : 2018-10-23

blank

02

Gowling WLG (Canada) LLP

arrow
The MedTech Conference
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
The MedTech Conference
Not Confirmed

TISAGENLECLEUCEL

Brand Name : KYMRIAH

Patent Number : 2878928

Filing Date : 2013-07-12

Strength per Unit : 1.2x10^6 to 6.0x10^8 CAR - positive viable T cells

Dosage Form : SUSPENSION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2033-07-12

Date Granted : 2023-03-14

blank